Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1942 May;21(3):281–286. doi: 10.1172/JCI101301

CHEMOTHERAPY OF PNEUMOCOCCIC MENINGITIS WITH SPECIAL REFERENCE TO SULFATHIAZOLE

Frank B Cooper 1, Paul Gross 1, Marion L Hagan 1
PMCID: PMC435141  PMID: 16694913

Full text

PDF
281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cooper F. B., Gross P., Lewis M. SULFAPYRIDINE, SULFANILAMIDE, AND SPECIFIC ANTISERUM IN EXPERIMENTAL TYPE III PNEUMOCOCCIC INFECTIONS. J Clin Invest. 1939 Jul;18(4):423–428. doi: 10.1172/JCI101057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Davis B. D. BINDING OF SULFONAMIDES BY PLASMA PROTEINS. Science. 1942 Jan 16;95(2455):78–78. doi: 10.1126/science.95.2455.78. [DOI] [PubMed] [Google Scholar]
  3. Gross P., Cooper F. B., Lewis M. Repair in experimental pneumococcic meningitis: A histopathological study of residual lesions in rats. Am J Pathol. 1939 Mar;15(2):193–198.3. [PMC free article] [PubMed] [Google Scholar]
  4. Long P. H. The Clinical Use of Sulfanilamide, Sulfapyridine, Sulfathiazole, Sulfaguanidine, and Sulfadiazine in the Prophylaxis and Treatment of Infections. Can Med Assoc J. 1941 Mar;44(3):217–227. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES